share_log

Sunshine Biopharma Q1 EPS $(2.00) Misses $(1.04) Estimate, Sales $7.54M Beat $7.00M Estimate

Benzinga ·  May 21 08:16

Sunshine Biopharma (NASDAQ:SBFM) reported quarterly losses of $(2.00) per share which missed the analyst consensus estimate of $(1.04) by 92.31 percent. This is a 75 percent increase over losses of $(8.00) per share from the same period last year. The company reported quarterly sales of $7.54 million which beat the analyst consensus estimate of $7.00 million by 7.73 percent. This is a 54.08 percent increase over sales of $4.89 million the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment